New Posts New Posts RSS Feed - Update on Strategies to Improve TNBC Treatment
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Update on Strategies to Improve TNBC Treatment

 Post Reply Post Reply
Author
123Donna View Drop Down
Senior Member
Senior Member
Avatar

Joined: Aug 24 2009
Location: St. Louis, MO
Status: Offline
Points: 13488
Post Options Post Options   Thanks (0) Thanks(0)   Quote 123Donna Quote  Post ReplyReply Direct Link To This Post Topic: Update on Strategies to Improve TNBC Treatment
    Posted: May 02 2022 at 10:41am

Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

Checkpoint Inhibitors, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.

When patients are newly diagnosed with TNBC, they should  undergo NGS-biomarker testing to check for PD-L1 status, BRCA and other biomarkers that can identify individuals who can benefit from treatment with newer precision cancer medicines and immunotherapy.

DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09)
11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15

Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down

Forum Software by Web Wiz Forums® version 12.01
Copyright ©2001-2018 Web Wiz Ltd.